RapidFor HbA1c Rapid Test Kit

Immunofluorescence-based test kit for quantitative measurement of glycated hemoglobin (HbA1c), enabling rapid diabetes screening and monitoring in clinical and point-of-care settings. Delivers precise glycemic control assessment through advanced immunofluorescence technology for both diagnostic and therapeutic applications.

HbA1c Test Kit using dry fluorescence immunoassay technology for rapid point-of-care glycemic control monitoring in diabetes management. Delivers quantitative hemoglobin A1c results for long-term blood glucose assessment, compatible with Lansion's portable and handheld analyzer platforms.

A diagnostic test kit for measuring glycated hemoglobin levels using fluorescence immunochromatography technology. It is used for diabetes screening and monitoring in point-of-care testing settings.

In vitro diagnostic reagent for diabetes screening and monitoring. Provides rapid results for on-site glucose metabolism assessment.

Rapid Test Kit for quick point-of-care diagnostic testing with results available within minutes. Designed for clinical settings to detect specific pathogens or biomarkers with minimal sample preparation. Ideal for emergency departments, clinics, and laboratory environments requiring fast diagnostic confirmation.

Diagnostic kit for rapid measurement of hemoglobin levels in blood samples. Provides results for anemia screening and monitoring.

An OEM diagnostic test kit for detecting glycated hemoglobin HbA1c. This kit is used in clinical diagnostics to measure HbA1c levels for diabetes assessment and monitoring.

A diagnostic test kit for measuring glycated hemoglobin using fluorescence immunochromatography method. This test is used to assess long-term blood glucose control in diabetic patients.

Liquid dual-reagent assay kit for hemoglobin A1c measurement in diabetes monitoring and diagnosis. Formulated to minimize operator error in preparation and execution for reliable glycemic control assessment.

Point-of-care test kit for HbA1c measurement using fluorescence immunoassay technology. Enables rapid diabetes monitoring and glycemic control assessment in clinical settings. Delivers quantitative results without laboratory infrastructure requirements.

A rapid immunological test for the detection of HIV antibodies. Provides quick results for HIV screening and diagnosis.

Laboratory test kit for evaluating blood glucose control in diabetic patients using HbA1c measurements at 7% threshold. Provides essential reference data for treatment plan adjustment and monitoring disease progression in diabetes management.